A multicenter clinical study: transmission of COVID-19 and impact on health and developmental outcomes among newborns of mothers with confirmed/suspected COVID-19

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000033960

Enrollment

Unknown

Registered

2020-06-19

Start date

2020-02-10

Completion date

Unknown

Last updated

2020-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Confirmed Group:Sample collection and follow-up

Suspected Group:Sample collection and follow-up

Control Group:Follow-up

Eligibility

Sex/Gender

All

Age

No minimum to 50 Years

Inclusion criteria

Inclusion criteria: 1. The Diagnosis and Treatment Scheme of Novel Coronavirus Pneumonia (Trial Seventh Edition) which was published by the National Health Commission of the Peoples Republic of China was used for the diagnostic criteria of mothers with confirmed or suspected COVID-19; 2. Obtain the informed consent of the patient's family.

Exclusion criteria

Exclusion criteria: 1. Information provided was incomplete; 2. The pregnant women did not undergo PCR testing of COVID-19; 3. The patients disapproved of the follow-up.

Design outcomes

Primary

Measure	Time frame
SARS-CoV-2 RNA;SARS-CoV-2 antibodies (IgM and IgG);Feeding methods;	—

Secondary

Measure	Time frame
Maternal postpartum self-rating depression scale (SDS);Maternal postpartum self-rating anxiety scale (SAS);Maternal-child attachment scale;Physical growth;Neurodevelopment;	—

Countries

China

Contacts

Public ContactShiwen Xia

Maternal and Child Health Hospital of Hubei Province

shiwenxia66@163.com+86 18971025669

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026